UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile
UCSF Team for High-Value Care

@ucsf_hvc

@UCSF-based team working to promote high-value care within the U.S. health care system.

ID: 1423371908620328960

calendar_today05-08-2021 19:55:01

123 Tweet

113 Followers

37 Following

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Incredible reporting from @ProPublica w/insights from @DeviceEvents and Rita Redberg. Rita Redberg raises concerns about delays in reporting and how they compromise patient safety. FDA Medical Devices

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Physicians need more education on FDA drug and device regulation. Sanket Dhruva, Aaron Kesselheim, and Rita Redberg explain the results of their recent Health Affairs research and propose solutions MedPage Today Genevieve Friedman  medpagetoday.com/opinion/second…

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Critical reporting from Pittsburgh Post-Gazette on the use of an unapproved medical device in patients without their informed consent. post-gazette.com/news/health/20…

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

From Sanket Dhruva & Rita Redberg: Given harms of overdiagnosis, early is not always better for cancer. Liquid biopsy trials must show reduction in all-cause death to claim they save lives - Only then will we know if healthy people benefit from these tests U.S. FDA FDA Medical Devices

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Patients deserve high-quality, accurate drug information. Join Steven Woloshin and Rita Redberg for a conversation on how to better communicate the benefits and risks of drugs at #DIA2024 in San Diego next Tuesday Drug Information Association (DIA) Arnold Ventures

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Moving forward with MCED tests without evidence that they save patient lives is inappropriate. Medicare coverage of MCEDs should require high-quality evidence, from RCTs, of mortality benefit from these tests CMSGov

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Investing time to generate mortality data for MCEDs is in patients' best interest - moving forward without evidence that MCEDs save patient lives is not and likely to be harmful, as Rita Redberg & coauthors wrote in JAMA Internal Medicine: doi.org/10.1001/jamain…

UCSF Team for High-Value Care (@ucsf_hvc) 's Twitter Profile Photo

Important piece on MitraClip in KFF Health News – serious adverse events, three recalls, questions of biased data and conflicts of interest and inconsistent evidence of effectiveness raise concerns about use of the device